154 related articles for article (PubMed ID: 33651392)
41. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
[TBL] [Abstract][Full Text] [Related]
42. Theory and practice of size exclusion chromatography for the analysis of protein aggregates.
Fekete S; Beck A; Veuthey JL; Guillarme D
J Pharm Biomed Anal; 2014 Dec; 101():161-73. PubMed ID: 24816223
[TBL] [Abstract][Full Text] [Related]
43. Size determination of hyaluronan using a gas-phase electrophoretic mobility molecular analysis.
Malm L; Hellman U; Larsson G
Glycobiology; 2012 Jan; 22(1):7-11. PubMed ID: 21752866
[TBL] [Abstract][Full Text] [Related]
44. A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor.
Kemptner J; Marchetti-Deschmann M; Müller R; Ivens A; Turecek P; Schwarz HP; Allmaier G
Rapid Commun Mass Spectrom; 2010 Mar; 24(6):761-7. PubMed ID: 20169558
[TBL] [Abstract][Full Text] [Related]
45. High perfomance liquid chromatography in pharmaceutical analyses.
Nikolin B; Imamović B; Medanhodzić-Vuk S; Sober M
Bosn J Basic Med Sci; 2004 May; 4(2):5-9. PubMed ID: 15629016
[TBL] [Abstract][Full Text] [Related]
46. Monolithic anion-exchange chromatography yields rhinovirus of high purity.
Allmaier G; Blaas D; Bliem C; Dechat T; Fedosyuk S; Gösler I; Kowalski H; Weiss VU
J Virol Methods; 2018 Jan; 251():15-21. PubMed ID: 28966037
[TBL] [Abstract][Full Text] [Related]
47. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
[TBL] [Abstract][Full Text] [Related]
48. Screening optimized protein purification protocols by coupling small-scale expression and mini-size exclusion chromatography.
Sala E; de Marco A
Protein Expr Purif; 2010 Dec; 74(2):231-5. PubMed ID: 20685308
[TBL] [Abstract][Full Text] [Related]
49. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
Xu Y; Wang D; Zhu B; Tang L; Wang J
J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
[TBL] [Abstract][Full Text] [Related]
50. The potential of differential mobility analysis coupled to MS for the study of very large singly and multiply charged proteins and protein complexes in the gas phase.
de la Mora JF; Ude S; Thomson BA
Biotechnol J; 2006 Sep; 1(9):988-97. PubMed ID: 16941442
[TBL] [Abstract][Full Text] [Related]
51. Utilization of a precolumn with size exclusion and reversed-phase modes for size-exclusion chromatographic analysis of polysorbate-containing protein aggregates.
Fukuda J; Iura T; Yanagihara S; Kano K
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():68-72. PubMed ID: 24576768
[TBL] [Abstract][Full Text] [Related]
52. Ion mobility measurements of nondenatured 12-150 kDa proteins and protein multimers by tandem differential mobility analysis-mass spectrometry (DMA-MS).
Hogan CJ; de la Mora JF
J Am Soc Mass Spectrom; 2011 Jan; 22(1):158-72. PubMed ID: 21472554
[TBL] [Abstract][Full Text] [Related]
53. [Applications of separation technology in novel coronavirus research, epidemic prevention and detection].
Li L; Zhu C; Zhao X; Qu F
Se Pu; 2021 Jul; 39(7):679-685. PubMed ID: 34227364
[TBL] [Abstract][Full Text] [Related]
54. Robust quantitation of basic-protein higher-order aggregates using size-exclusion chromatography.
Gervais D; Downer A; King D; Kanda P; Foote N; Smith S
J Pharm Biomed Anal; 2017 May; 139():215-220. PubMed ID: 28292680
[TBL] [Abstract][Full Text] [Related]
55. Development of native mass spectrometry with nanoelectrospray ionization coupled to size exclusion chromatography for proteins.
Saikusa K; Kinumi T; Kato M
Rapid Commun Mass Spectrom; 2022 Nov; 36(21):e9395. PubMed ID: 36068720
[TBL] [Abstract][Full Text] [Related]
56. On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations.
He Y; Brown P; Bailey Piatchek MR; Carroll JA; Jones MT
J Chromatogr A; 2019 Feb; 1586():72-81. PubMed ID: 30551943
[TBL] [Abstract][Full Text] [Related]
57. Chromatography and its hyphenation to mass spectrometry for extracellular vesicle analysis.
Pocsfalvi G; Stanly C; Fiume I; Vékey K
J Chromatogr A; 2016 Mar; 1439():26-41. PubMed ID: 26830636
[TBL] [Abstract][Full Text] [Related]
58. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
59. Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals.
Al-Ghobashy MA; Mostafa MM; Abed HS; Fathalla FA; Salem MY
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():1-9. PubMed ID: 28578190
[TBL] [Abstract][Full Text] [Related]
60. Extending the limits of size exclusion chromatography: Simultaneous separation of free payloads and related species from antibody drug conjugates and their aggregates.
Goyon A; Sciascera L; Clarke A; Guillarme D; Pell R
J Chromatogr A; 2018 Mar; 1539():19-29. PubMed ID: 29397979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
